PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia · Delayed Price · Currency is IDR 254.00
0.00 (0.00%)
At close: Jul 21, 2026
IDX:OBAT Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 18,845 | 22,642 | 29,426 | 11,974 | 12,384 | 15,649 |
Depreciation & Amortization | 687.11 | 370.34 | 2,322 | 2,100 | 1,273 | 742.44 |
Other Operating Activities | 5,408 | 711.31 | -18,785 | -57.2 | 815.8 | 2,257 |
Operating Cash Flow | 24,941 | 23,724 | 12,962 | 14,017 | 14,473 | 18,648 |
Operating Cash Flow Growth | 987.57% | 83.02% | -7.52% | -3.15% | -22.39% | - |
Capital Expenditures | -21,193 | -20,520 | -6,607 | -7,488 | -7,325 | -3,740 |
Sale of Property, Plant & Equipment | 387.95 | 110.09 | - | - | - | - |
Cash Acquisitions | -2,124 | -2,124 | -606.87 | 250 | - | - |
Investment in Securities | -25,805 | -12,448 | -641.21 | 20.26 | -375.08 | - |
Other Investing Activities | 256 | 256 | -995 | -250 | -225 | 35 |
Investing Cash Flow | -48,479 | -34,726 | -8,850 | -7,468 | -7,925 | -3,705 |
Short-Term Debt Issued | - | - | - | - | 5,978 | - |
Long-Term Debt Issued | - | 3,000 | 8,210 | 4,375 | - | - |
Total Debt Issued | 3,000 | 3,000 | 8,210 | 4,375 | 5,978 | - |
Short-Term Debt Repaid | - | - | - | - | - | -5,582 |
Long-Term Debt Repaid | - | -11,668 | -588.43 | -75 | - | - |
Total Debt Repaid | -15,329 | -11,668 | -588.43 | -75 | - | -5,582 |
Net Debt Issued (Repaid) | -12,329 | -8,668 | 7,622 | 4,300 | 5,978 | -5,582 |
Issuance of Common Stock | 28,132 | 59,500 | 19,500 | - | 1,500 | - |
Common Dividends Paid | -13,424 | -13,424 | -25,050 | -7,850 | -15,000 | -8,000 |
Other Financing Activities | - | -3,457 | -3,800 | - | - | - |
Financing Cash Flow | 2,379 | 33,951 | -1,728 | -3,550 | -7,522 | -13,582 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | 0 | - |
Net Cash Flow | -21,159 | 22,948 | 2,384 | 2,998 | -974.19 | 1,361 |
Free Cash Flow | 3,747 | 3,204 | 6,355 | 6,528 | 7,148 | 14,908 |
Free Cash Flow Growth | - | -49.59% | -2.65% | -8.67% | -52.05% | - |
Free Cash Flow Margin | 2.14% | 2.00% | 5.27% | 11.47% | 18.57% | 39.38% |
Free Cash Flow Per Share | 6.25 | 5.34 | 10.59 | 15.18 | 15.44 | 32.20 |
Cash Interest Paid | 1,962 | 1,832 | 1,381 | 1,253 | 845.28 | 279.34 |
Levered Free Cash Flow | -2,562 | -4,788 | -2,665 | 2,995 | 3,865 | - |
Unlevered Free Cash Flow | -1,336 | -3,643 | -1,802 | 3,779 | 4,393 | - |